Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.
Conclusions: ABL is an effective and well-tolerated treatment for women with postmenopausal osteoporosis at high risk for fracture. Its therapeutic effects are sustained with subsequent ALN therapy.
PMID: 32969719 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Headache | Hormones | Migraine | Orthopaedics | Osteoporosis | Research | Study | Women